Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Ricardo Rezola"'
Autor:
Angela M. Araujo, Andrea Abaurrea, Peio Azcoaga, Joanna I. López-Velazco, Sara Manzano, Javier Rodriguez, Ricardo Rezola, Leire Egia-Mendikute, Fátima Valdés-Mora, Juana M. Flores, Liam Jenkins, Laura Pulido, Iñaki Osorio-Querejeta, Patricia Fernández-Nogueira, Nicola Ferrari, Cristina Viera, Natalia Martín-Martín, Alexandar Tzankov, Serenella Eppenberger-Castori, Isabel Alvarez-Lopez, Ander Urruticoechea, Paloma Bragado, Nicholas Coleman, Asís Palazón, Arkaitz Carracedo, David Gallego-Ortega, Fernando Calvo, Clare M. Isacke, María M. Caffarel, Charles H. Lawrie
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 19 (2022)
Externí odkaz:
https://doaj.org/article/3d06a870071548a9a083041ef64b61ed
Autor:
Luiza I. Hernandez, Marcos J. Araúzo-Bravo, Daniela Gerovska, Ricardo Rezola Solaun, Isabel Machado, Alien Balian, Juliana Botero, Tania Jiménez, Olaia Zuriarrain Bergara, Lide Larburu Gurruchaga, Ander Urruticoechea, Frank J. Hernandez
Publikováno v:
Cancers, Vol 13, Iss 2, p 276 (2021)
Breast cancer is one of the most common pathologies diagnosed in the clinical practice. Despite major advancements in diagnostic approaches, there is no widely accepted biomarker in the clinical practice that can diagnose breast malignancy. Confirmat
Externí odkaz:
https://doaj.org/article/97f3b5df2d694254b07ed63d8f50e90a
Autor:
Ibai Goicoechea, Ricardo Rezola, María Arestin, María M. Caffarel, Ana Rosa Cortazar, Lorea Manterola, Marta Fernandez-Mercado, María Armesto, Carla Sole, Erika Larrea, Angela M. Araujo, Nerea Ancizar, Arrate Plazaola, Ander Urruticoechea, Arkaitz Carracedo, Irune Ruiz, Isabel Alvarez Lopez, Charles H. Lawrie
Publikováno v:
F1000Research, Vol 6 (2018)
Background: The outcome for oestrogen receptor positive (ER+) breast cancer patients has improved greatly in recent years largely due to targeted therapy. However, the presence of involved multiple synchronous lymph nodes remains associated with a po
Externí odkaz:
https://doaj.org/article/f442f153d139472fba8604035732eb6d
Autor:
Hernandez, Luiza I., Arauzo-Bravo, Marcos J., Gerovska, Daniela, Solaun, Ricardo Rezola, Machado, Isabel, Balian, Alien, Botero, Juliana, Jimenez, Tania, Zuriarrain Bergara, Olaia, Larburu Gurruchaga, Lide, Urruticoechea, Ander, Hernandez, Frank
Publikováno v:
Cancers, Vol 13, Iss 276, p 276 (2021)
Cancers
Volume 13
Issue 2
Cancers
Volume 13
Issue 2
Simple Summary A diagnostic biomarker for the detection of breast cancer remains an unmet clinical need despite decades of intensive research efforts. Herein, we describe, for the first time, the use of nuclease activity as a biomarker to discriminat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::603dabed1a66b16d226e187bb29e86ca
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-173418
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-173418
Publikováno v:
Revista de Senología y Patología Mamaria. 25:107-115
Resumen En los ultimos anos se ha identificado un pequeno numero de celulas en los tumores con caracteristicas de celulas madre que se han observado en distintos tipos de tumor, incluido el cancer de mama. Estas celulas, las celulas madre tumorales,
Autor:
Ainoha Hernándiz, Carles Casterá, Federico Rojo, Irune Ruiz, Alicia Cordoba, Javier Martin de Francisco Hernandez, Francesc Riu, Jose Miguel Lazaro, Ricardo Rezola, Tomás García-Caballero, Luis Polo, Victoria M. Coupe, Rafael Cano Muñoz, Juan de Dios Barranco, David Hardisson, Francisco Sevilla, Marcos Martínez Benaclocha, J.M. de la Cámara de las Heras, Javier Alba, Laia Bernet
Publikováno v:
Bernet, L, Benaclocha, M M, Castera, C, Munoz, R C, Sevilla, F, Alba, J, Barranco, J D, Cordoba, A, Garcia-Caballero, T, Hardisson, D, Hernandez, J M D, Lazaro, J M, Polo, L, Riu, F, Rezola, R, Rojo, F, Ruiz, I, Hernandiz, A, de las Heras, J M D & Coupé, V M H 2012, ' mRNA In Situ Hybridization (HistoSonda): A New Diagnostic Tool for HER2-Status in Breast Cancer-A Multicentric Spanish Study ', Diagnostic Molecular Pathology, vol. 21, no. 2, pp. 84-92 . https://doi.org/10.1097/PDM.0b013e3182360b0a
Diagnostic Molecular Pathology, 21(2), 84-92. Lippincott Williams and Wilkins
Diagnostic Molecular Pathology, 21(2), 84-92. Lippincott Williams and Wilkins
Monoclonal therapies could represent baseline-personalized medicine for patients with neoplasia. One of the most successful examples is Trastuzumab, a humanized antibody against epidermal growth factor receptor 2. Human epidermal growth factor recept
Autor:
Irune Ruiz, Ricardo Rezola, Jose Luis Todolí Torró, José Medrano, Laia Bernet, Xavier Matias-Guiu, Rafael Cano, Francisco Sevilla, Blai Ballester, María José Robles-Frías, Begoña Vieites, Marcos Carrasco Martínez, Ana Velasco, Lluisa Morell, José Palacios, Basilio Dueñas
Publikováno v:
Histopathology. 58:863-869
Bernet L, Cano R, Martinez M, Duenas B, Matias-Guiu X, Morell L, Palacios J, Rezola R, Robles-Frias M, Ruiz I, Velasco A, Vieites B, Sevilla F, Torro J, Medrano J & Ballester B (2011) Histopathology 58, 863–869 Diagnosis of the sentinel lymph node
Autor:
A. Abaurrea, I. Alvarez Lopez, Angela M Araujo, Ricardo Rezola, Charles H. Lawrie, A. Urrutikoetxea, María M. Caffarel
Publikováno v:
ESMO Open. 3:A296
Introduction Triple Negative (TN) breast tumours have poor prognosis, lack of targeted therapies and are often refractory to conventional chemotherapy treatments. Therefore, finding new therapeutic targets for those tumours is an unmet need with high
Autor:
Karmele Mujika-Eizmendi, M.ª Jesús Michelena-Echeveste, Kepa Elorriaga-Barandiarán, Ricardo Rezola-Solaun, Isabel Pericás-O’Callaghan, Elvira Soga-García, Juan José Albistur-Tomé, Iñaki Arias-Camisón-Montero
Publikováno v:
Revista Española de Patología. 42:39-45
Resumen Antecedentes Los melanomas afectando inicialmente ganglios linfaticos, sin lesion primaria identificada, se han incluido tradicionalmente dentro del grupo de melanomas metastaticos de origen desconocido (MMOD). Hay variacion en los datos apor
Autor:
I. Alvarez Lopez, Angela M Araujo, Ricardo Rezola, María M. Caffarel, Charles H. Lawrie, A. Abaurrea
Publikováno v:
Annals of Oncology. 28:v2